"head and neck cancer squamous cell carcinoma" trang 3 - tải miễn phí từ tailieunhanh
Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial

Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial
8    7    1
αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma

αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma
8    73    1
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe

Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe
12    26    1
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
10    1    1
The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
10    95    1
MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma

MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma
14    1    1
Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas
11    58    1
Circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway

Circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway
16    20    1
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
12    1    1
Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis
9    92    0
Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis
9    66    1
Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: Tertiary referral center experience

Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: Tertiary referral center experience
9    82    0
Current Research in Head and Neck Cancer

Current Research in Head and Neck Cancer
215    50    0
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma

Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
14    71    0
Optimal cutoff of pretreatment neutrophilto-lymphocyte ratio in head and neck cancer patients: A meta-analysis and validation study

Optimal cutoff of pretreatment neutrophilto-lymphocyte ratio in head and neck cancer patients: A meta-analysis and validation study
9    64    1
Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician

Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician
10    63    1
Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-MycAKT1-p38 MAPK signalling pathways

Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-MycAKT1-p38 MAPK signalling pathways
9    75    0
Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma

Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma
7    46    1
SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma

SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma
10    44    1
Treatment of supraglottic squamous cell carcinoma with advanced technologies: Observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL)

Treatment of supraglottic squamous cell carcinoma with advanced technologies: Observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL)
12    8    1